William D. Waddill sold $969K of Protagonist Therapeutics (PTGX)

Executed Jun 10, disclosed Jun 11, 1 day later.

Value, as filed

$969K

9,000 sh × $107.68

Executed

Jun 10

the trade date, as filed

Disclosed

Jun 11

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

William D. Waddill Director profile →

William D. Waddill (Director) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $1.7M of PTGX (20,000 sh × $83.68, as filed), executed Feb 6.

The name

PTGX

Protagonist Therapeutics, Inc. PTGX · Healthcare · 37 filings in 24 months ticker →

Healthcare · Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by William D. Waddill in PTGX

PTGXSALE Protagonist Therapeutics, Inc. $1.1M
9,000 sh × $117.94
Exec Jun 23
Filed Jun 25 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $897K
9,000 sh × $99.64
Exec May 29
Filed Jun 1 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $1.7M
20,000 sh × $83.68
Exec Feb 6
Filed Feb 6 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $979K
12,000 sh across 2 lots
Exec Oct 10 2025
Filed Oct 14 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $257K
4,000 sh × $64.25
Exec Sep 22 2025
Filed Sep 24 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $237K
4,000 sh × $59.25
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $217K
4,000 sh × $54.25
Exec Mar 17 2025
Filed Mar 19 2025 · 5:30 PM ET